Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

被引:288
作者
Leucht, Stefan [1 ]
Hierl, Sandra [1 ]
Kissling, Werner [1 ]
Dold, Markus [1 ]
Davis, John M. [2 ]
机构
[1] Tech Univ Munich, Dept Psychiat & Psychotherapy, Klinikum Rechts Isar, D-81675 Munich, Germany
[2] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA
关键词
PLACEBO-CONTROLLED TRIALS; SHORT-TERM EFFICACY; RANDOMIZED-TRIALS; HEART-FAILURE; DRUG TRIALS; TRICYCLIC ANTIDEPRESSANTS; AFFECTIVE-DISORDERS; MAJOR DEPRESSION; BETA-AGONISTS; EFFECT SIZE;
D O I
10.1192/bjp.bp.111.096594
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background The efficacy of psychopharmacological treatments has been called into question. Psychiatrists are unfamiliar with the effectiveness of common medical drugs. Aims To put the efficacy of psychiatric drugs into the perspective of that of major medical drugs. Method We searched Medline and the Cochrane Library for systematic reviews on the efficacy of drugs compared with placebo for common medical and psychiatric disorders, and systematically presented the effect sizes for primary efficacy outcomes. Results We included 94 meta-analyses (48 drugs in 20 medical diseases, 16 drugs in 8 psychiatric disorders). There were some general medical drugs with clearly higher effect sizes than the psychotropic agents, but the psychiatric drugs were not generally less efficacious than other drugs. Conclusions Any comparison of different outcomes in different diseases can only serve the purpose of a qualitative perspective. The increment of improvement by drug over placebo must be viewed in the context of the disease's seriousness, suffering induced, natural course, duration, outcomes, adverse events and societal values.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 103 条
[71]  
Myers RP, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000370, DOI 10.1002/14651858.CD000370]
[72]  
National Collaborating Centre for Chronic Conditions (Great Britain), 2006, PARK DIS NAT CLIN GU
[73]   The salmeterol multicenter asthma research trial - A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol [J].
Nelson, HS ;
Weiss, ST ;
Bleecker, ER ;
Yancey, SW ;
Dorinsky, PM .
CHEST, 2006, 129 (01) :15-26
[74]  
Nelson RL, 2009, COCHRANE DB SYST REV, V1
[75]  
Ni CM, 2005, COCHRANE DB SYST REV, V4
[76]   BTS guideline for emergency oxygen use in adult patients (vol 63, Suppl 6, pg vi1, 2008) [J].
O'Driscoll, B. R. ;
Howard, L. S. ;
Davison, A. G. .
THORAX, 2009, 64 (01)
[77]  
Rice G.P., 2001, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD002002, DOI 10.1002/14651858.CD002002]
[78]   Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation [J].
Rising, Kristin ;
Bacchetti, Peter ;
Bero, Lisa .
PLOS MEDICINE, 2008, 5 (11) :1561-1570
[79]  
Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x
[80]   Meta-analysis:: Effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths [J].
Salpeter, Shelley R. ;
Buckley, Nicholas S. ;
Ormiston, Thomas M. ;
Salpeter, Edwin E. .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) :904-912